Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mylan To Disallow Wholesaler Investment Buying Ahead Of Price Increases

Executive Summary

Mylan will no longer allow wholesalers to investment buy ahead of price increases, CEO Milan Puskar said during a June 8 conference call.

You may also be interested in...

Watson To Acquire Schein: Generic Business Projected At $800 Mil. In 2001

Watson expects its generic drug business to top $800 mil. in revenues during 2001 after it completes the proposed acquisition of Schein.

Mylan Lorazepam Price Triples; Firm Cites Losses For Many Products

Mylan has increased the price of its generic version of lorazepam more than threefold. On March 3, the price for a bottle of 100 lorazepam 5 mg tablets increased from $16.95 to $64.31.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts